Pediatric Status Epilepticus Emergency Medication Dosing Protocol (AES / ESETT) Calculator | Clinical Interpretation & Formula

High Yield Prometric Topic•Pediatrics

Tested on Gulf Medical Boards (DHA, SMLE, MOH & HAAD)

Clinical calculations and diagnostic scoring systems like Pediatric Status Epilepticus Emergency Medication Dosing Protocol (AES / ESETT) frequently appear on Prometric exams. Master high-yield clinical vignettes with instant AI-powered pathophysiology rationales.

Practice Pediatrics MCQs Take Free Trial

Clinical Significance & Diagnostic Standard

2026 Clinical Reference

What is the Pediatric Status Epilepticus Emergency Medication Dosing Protocol (AES / ESETT)?

📋Clinical Summary & Definition Capsule

The Pediatric Status Epilepticus Emergency Medication Dosing Protocol (AES / ESETT) is an evidence-based clinical decision rule engineered to quantify diagnostic probability, stratify clinical severity, and guide therapeutic decision-making in pediatrics practice. Implements the American Epilepsy Society (AES) and ESETT trial pediatric status epilepticus guidelines, calculating exact weight-based dosages and safety ceilings for Lorazepam, Midazolam, Levetiracetam (Keppra 60 mg/kg), Fosphenytoin (20 mg PE/kg), and Valproate (40 mg/kg). Clinical scoring tools like Pediatric Status Epilepticus Emergency Medication Dosing Protocol (AES / ESETT) are essential in acute and outpatient management, enabling clinicians to objectively differentiate between low-risk candidates suitable for conservative therapy and high-risk patients requiring urgent interventions. Verified against current 2026 clinical standards, this tool is extensively tested on Gulf health authority licensing exams including DHA (Dubai), SMLE (Saudi Arabia), MOH, HAAD/DOH (Abu Dhabi), OMSB (Oman), and QCHP (Qatar).

💡Clinical Pearls & Diagnostic Utility

Mandatory pediatric emergency resuscitation algorithm shown in landmark clinical trials to achieve > 70% seizure cessation within 60 minutes.

Mathematical Formulation

Formula & Calculation Parameters

The mathematical equation and clinical variables required to calculate Pediatric Status Epilepticus Emergency Medication Dosing Protocol (AES / ESETT):

AES / ESETT Dosing:

• Lorazepam IV: 0.1 mg/kg (max 4 mg)

• Midazolam IN/IM: 0.2 mg/kg (max 10 mg)

• Levetiracetam (Keppra) IV: 60 mg/kg (max 4500 mg)

• Fosphenytoin IV: 20 mg PE/kg (max 1500 mg PE)

• Valproate IV: 40 mg/kg (max 3000 mg)

Risk Stratification

Score Interpretation & Clinical Stratification

Score Range	Clinical Interpretation	Risk Tier
≤ 5	Early Seizure Stage (< 5 min: ABCs & Glucose)	blue
6 – 20	Phase 1 Established Status (5–20 min: First-Line Benzodiazepines)	yellow
≥ 21	Phase 2 / Refractory Status (≥ 20 min: Second-Line ESETT Anticonvulsants / PICU)	red

Clinical Limitations & Contraindications

When to Exercise Caution

Avoid Valproate in children < 2 years with suspected inborn errors of metabolism or POLG mutations due to risk of fatal fulminant hepatic necrosis.

Peer-Reviewed Medical Literature

•Glauser T, et al. Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr. 2016;16(1):48-61.
•Kapur J, et al. Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus (ESETT Trial). N Engl J Med. 2019;381(22):2103-2113.

Clinical Decision Network